These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33779448)

  • 1. Understanding glomerular diseases through proteomics.
    Mavrogeorgis E; Mischak H; Beige J; Latosinska A; Siwy J
    Expert Rev Proteomics; 2021 Feb; 18(2):137-157. PubMed ID: 33779448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD273, a new proteomics classifier assessing CKD and its prognosis.
    Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
    PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
    Critselis E; Lambers Heerspink H
    Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics and personalized medicine: a focus on kidney disease.
    Siwy J; Mischak H; Zürbig P
    Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.
    Filip S; Pontillo C; Peter Schanstra J; Vlahou A; Mischak H; Klein J
    Expert Rev Proteomics; 2014 Oct; 11(5):535-48. PubMed ID: 24957818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
    Siwy J; Zürbig P; Argiles A; Beige J; Haubitz M; Jankowski J; Julian BA; Linde PG; Marx D; Mischak H; Mullen W; Novak J; Ortiz A; Persson F; Pontillo C; Rossing P; Rupprecht H; Schanstra JP; Vlahou A; Vanholder R
    Nephrol Dial Transplant; 2017 Dec; 32(12):2079-2089. PubMed ID: 27984204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!
    Mischak H
    Nephrol Dial Transplant; 2015 Apr; 30(4):532-7. PubMed ID: 25801638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary proteomics in the assessment of chronic kidney disease.
    Mullen W; Delles C; Mischak H;
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):654-61. PubMed ID: 21885967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease.
    Verbeke F; Siwy J; Van Biesen W; Mischak H; Pletinck A; Schepers E; Neirynck N; Magalhães P; Pejchinovski M; Pontillo C; Lichtinghagen R; Brand K; Vlahou A; De Bacquer D; Glorieux G
    Nephrol Dial Transplant; 2021 Apr; 36(5):811-818. PubMed ID: 31837226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease.
    Ferlizza E; Isani G; Dondi F; Andreani G; Vasylyeva K; Bellei E; Almeida AM; Matzapetakis M
    J Proteomics; 2020 Jun; 222():103795. PubMed ID: 32335294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics-Based Machine Learning Approach as an Alternative to Conventional Biomarkers for Differential Diagnosis of Chronic Kidney Diseases.
    Glazyrin YE; Veprintsev DV; Ler IA; Rossovskaya ML; Varygina SA; Glizer SL; Zamay TN; Petrova MM; Minic Z; Berezovski MV; Kichkailo AS
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
    Pontillo C; Mischak H
    Clin Kidney J; 2017 Apr; 10(2):192-201. PubMed ID: 28694965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PeptiCKDdb-peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease.
    Krochmal M; Fernandes M; Filip S; Pontillo C; Husi H; Zoidakis J; Mischak H; Vlahou A; Jankowski J
    Database (Oxford); 2016; 2016():. PubMed ID: 27589965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis.
    Tracz J; Luczak M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.
    Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N
    Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in proteomic profiling of pediatric kidney diseases.
    Cummins TD; Korte EA; Bhayana S; Merchant ML; Barati MT; Smoyer WE; Klein JB
    Pediatr Nephrol; 2022 Oct; 37(10):2255-2265. PubMed ID: 35220505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.
    Glorieux G; Mullen W; Duranton F; Filip S; Gayrard N; Husi H; Schepers E; Neirynck N; Schanstra JP; Jankowski J; Mischak H; Argilés À; Vanholder R; Vlahou A; Klein J
    Nephrol Dial Transplant; 2015 Nov; 30(11):1842-52. PubMed ID: 26160894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.